Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Preoperative Prediction of Glypican-3 Expression in Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasound Radiomics
Journal of Hepatocellular Carcinoma
2026
Yang S.
Open Access
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Molecular Cancer
December 2024
Chan Y.T.
Open Access
Glypican-3, Vascular Endothelial Growth Factor and Golgi Protein-73 for Differentiation between Liver Cirrhosis and Hepatocellular Carcinoma
Asian Pacific Journal of Cancer Prevention
2023
Mamdouh S.
Open Access
European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation
Transplant International
2023
Berenguer M.
Open Access
Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
Frontiers in Oncology
11 August 2022
Gonvers S.
Open Access
The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma
Journal of Nanobiotechnology
December 2021
Yi B.
Open Access
The value of contrast-enhanced ultrasound in predicting postoperative recurrence of hepatocellular carcinoma: A protocol for systematic review and meta-analysis
Medicine United States
4 June 2021
Fu J.
Open Access
Serum-derived exosomes function as tumor antigens in patients with advanced hepatocellular carcinoma
Molecular Immunology
June 2021
Shi S.
Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation
European Journal of Pharmacology
15 January 2020
Mo Y.
Developments in predictive biomarkers for hepatocellular carcinoma therapy
Expert Review of Anticancer Therapy
2 January 2020
Andrea C.G.
Independent risk factors for disease recurrence after surgery in patients with hepatitis B virus-related hepatocellular carcinoma 3 cm in diameter
Gastroenterology Report
1 August 2019
He L.L.
Open Access
Meta-analysis and systematic review of prognostic significance of Glypican-3 in patients with hepatitis B-related hepatocellular carcinoma
Virusdisease
1 June 2019
Moudi B.
Open Access
A twenty-year review of clinical liver transplantation
Chinese Critical Care Medicine
March 2019
Zhongyang S.
Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma an updated meta-analysis
Medicine United States
June 2018
Zhang J.
Open Access
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Medicinal Research Reviews
March 2018
Zhou F.
Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma
Journal of Experimental and Clinical Cancer Research
27 August 2016
Yin F.
Open Access
Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance
Clinical and Translational Oncology
1 August 2016
Yang L.
Association of histone methyltransferase G9a and overall survival after liver resection of patients with hepatocellular carcinoma with a median observation of 40 months
Medicine United States
1 January 2016
Bai K.
Open Access
Advances in the study of oncofetal antigen glypican-3 expression in HBV-related hepatocellular carcinoma
Bioscience Trends
2016
Yao M.
Open Access
The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/catenin signaling pathway
International Journal of Oncology
January 2016
Gai J.Q.
Open Access
Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
Hepatobiliary and Pancreatic Diseases International
15 August 2015
Wang L.
Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells
Molecular Medicine Reports
1 May 2015
Wang Y.
Open Access
Silencing of the glypican-3 gene affects the biological behavior of human hepatocellular carcinoma cells
Molecular Medicine Reports
1 December 2014
Qi X.H.